WuXi Biologics Executive and Leadership Team

Jimmy Li, the Chief Executive Officer at WuXi Biologics, directs the company's overall strategic vision and operational execution. Overseeing all business units, the Chief Executive Officer ensures alignment with WuXi Biologics' mission to accelerate and transform biologics discovery, development, and manufacturing. This leadership position involves driving market expansion and fostering innovation across the organization. By optimizing resource allocation and guiding corporate policy, Jimmy Li directly impacts the company's growth trajectory and its ability to deliver cutting-edge solutions to the global biopharmaceutical industry. Ultimately, Li secures WuXi Biologics' competitive advantage and long-term financial stability through astute leadership and strategic foresight.

Ming Tu, the Chief Financial Officer at WuXi Biologics, manages the company's financial strategy and fiscal operations. Overseeing all financial planning, reporting, and investment activities, the Chief Financial Officer ensures robust financial health and sustainable growth. This executive position involves optimizing capital structure, managing risk, and driving profitability across global operations. By providing critical financial insights and guidance, Ming Tu directly supports strategic decision-making and resource allocation. Tu's stewardship of WuXi Biologics' finances underpins the company's capacity for continued expansion and its ability to fund groundbreaking research and development initiatives, ensuring long-term value creation for stakeholders.

Jijie Gu, the Chief Scientific Officer, President of Global Biologics Research at WuXi Biologics, leads the company's extensive research and development efforts. Overseeing all scientific discovery and early-stage research programs, the Chief Scientific Officer, President of Global Biologics Research drives the innovation engine for novel biologics. This position involves setting the scientific agenda, fostering collaborations, and ensuring the highest standards of research integrity. By guiding the exploration of new therapeutic modalities and platform technologies, Jijie Gu directly advances WuXi Biologics' mission to empower global partners. Gu's scientific leadership is fundamental to the company's ability to tackle complex biological challenges and bring life-saving therapies to patients.

Xuejun Gu, the Chief Technology Officer at WuXi Biologics, architects the company's technological infrastructure and innovation pipeline. Overseeing the development and implementation of advanced R&D platforms, the Chief Technology Officer ensures WuXi Biologics remains at the forefront of biologics drug development technology. This critical role involves identifying and integrating novel scientific advancements to enhance service offerings and operational efficiency. By driving technological upgrades and fostering a culture of scientific excellence, Xuejun Gu directly supports the company's commitment to providing integrated, end-to-end solutions. Gu's leadership ensures the continuous evolution of WuXi Biologics' technological capabilities, solidifying its position as a global leader in the field.

Sherry Gu, the Executive Vice President & Chief Technology Officer at WuXi Biologics, spearheads the advancement of the company's technological capabilities and operational excellence. Overseeing key technology initiatives and driving process innovation, the Executive Vice President & Chief Technology Officer ensures WuXi Biologics maintains its competitive edge in biologics development. This role focuses on translating scientific breakthroughs into scalable, efficient manufacturing processes. By enhancing platform technologies and optimizing workflows, Sherry Gu directly contributes to the acceleration of drug development timelines for clients worldwide. Gu's leadership reinforces WuXi Biologics' commitment to delivering high-quality, innovative solutions and expanding its global service network.